In addition, HMGB1/PTEN/β-catenin signaling is a novel pathway that regulates the regulatory T-cell (Treg) development and provides a potential therapeutic target in sepsis-induced lung injury [16]. The gene discussed is HMGB1; the disease is Sepsis.